Search
Search titles only
By:
Search titles only
By:
Home
Forums
New posts
Search forums
What's new
New posts
New profile posts
Latest activity
Members
Current visitors
New profile posts
Search profile posts
Log in
Register
Search
Search titles only
By:
Search titles only
By:
New posts
Search forums
Menu
Install the app
Install
Reply to Thread
Guest, we'd love to know what you think about the forum! Take the
Diabetes Forum Survey 2024 »
Home
Forums
Food and Nutrition
Low-carb Diet Forum
Digestive Enzymes: An Unexpected Diabetes Game Changer
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Message
<blockquote data-quote="Winnie53" data-source="post: 1177367" data-attributes="member: 160246"><p>[USER=219467]@bulkbiker[/USER] those are the ones. <img src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" class="smilie smilie--sprite smilie--sprite1" alt=":)" title="Smile :)" loading="lazy" data-shortname=":)" /></p><p></p><p>This is some of the information I found in my travels yesterday. It's from the 2014 study, <em>Evaluation of amylase activity in patients with type 2 diabetes mellitus</em>, listed above...</p><p></p><p><em>"The majority of diabetic research has been focused on</em></p><p><em></em></p><p><em>normalization of hyperglycemia and abnormal lipid profile</em></p><p><em></em></p><p><em>to the other hand, very little concern on pancreatic exocrine</em></p><p><em></em></p><p><em>function in diabetes has been paid. The present study,</em></p><p><em></em></p><p><em>investigated the changes in serum pancreatic amylase in</em></p><p><em></em></p><p><em>type 2 diabetic patients compared with normal healthy</em></p><p><em></em></p><p><em>individuals.</em></p><p><em></em></p><p><em>By study the amylase activity in this work revealed that</em></p><p><em></em></p><p><em>decrease in activity of amylase in diabetic patients in</em></p><p><em></em></p><p><em>comparism with control and there is significant difference</em></p><p><em></em></p><p><em>at p value < 0.05.</em></p><p><em></em></p><p><em>Low level of amylase in the body is mostly resulted due</em></p><p><em></em></p><p><em>to consumption of high amounts of carbohydrates. This is</em></p><p><em></em></p><p><em>the case with amylase deficiency in people with fat</em></p><p><em></em></p><p><em>intolerance. Amylase catalyzes starch and complex</em></p><p><em></em></p><p><em>carbohydrates. So, the higher the amount of these nutrients</em></p><p><em></em></p><p><em>in the body, the more is the requirement of amylase.</em></p><p><em></em></p><p><em>Eventually, the level of amylase falls down from the normal</em></p><p><em></em></p><p><em>recommended level, thus manifesting amylase deficiency</em></p><p><em></em></p><p><em>symptoms[30,31].</em></p><p><em></em></p><p><em>Diabetes does not only cause impairment in the</em></p><p><em></em></p><p><em>metabolism of sugars but is also associated with abnormal</em></p><p><em></em></p><p><em>metabolism of fats and proteins. Therefore all three key</em></p><p><em></em></p><p><em>enzymes — lipase, protease and amylase — are important</em></p><p><em></em></p><p><em>in managing diabetes because they will help digest all three</em></p><p><em></em></p><p><em>groups of nutrients: proteins, fats and sugars[16].</em></p><p><em></em></p><p><strong></strong></p><p><strong><em>5. Conclusions</em></strong></p><p><strong></strong></p><p><strong></strong></p><p><em>Although most of diabetic research has been focused on</em></p><p><em></em></p><p><em>dyslipidemia as a major risk factor for cardiac, cerebral and</em></p><p><em></em></p><p><em>renal complications, the present study clearly illustrates an</em></p><p><em></em></p><p><em>impairment of pancreatic exocrine function in type 2</em></p><p><em></em></p><p><em>diabetes mellitus. The suggestion that an analysis of serum</em></p><p><em></em></p><p><em>pancreatic enzymes could be an additional informative</em></p><p><em></em></p><p><em>parameter for the assessment of chronic and progress of the</em></p><p><em></em></p><p><em>illness as well as the response to therapy."</em></p></blockquote><p></p>
[QUOTE="Winnie53, post: 1177367, member: 160246"] [USER=219467]@bulkbiker[/USER] those are the ones. :) This is some of the information I found in my travels yesterday. It's from the 2014 study, [I]Evaluation of amylase activity in patients with type 2 diabetes mellitus[/I], listed above... [I]"The majority of diabetic research has been focused on normalization of hyperglycemia and abnormal lipid profile to the other hand, very little concern on pancreatic exocrine function in diabetes has been paid. The present study, investigated the changes in serum pancreatic amylase in type 2 diabetic patients compared with normal healthy individuals. By study the amylase activity in this work revealed that decrease in activity of amylase in diabetic patients in comparism with control and there is significant difference at p value < 0.05. Low level of amylase in the body is mostly resulted due to consumption of high amounts of carbohydrates. This is the case with amylase deficiency in people with fat intolerance. Amylase catalyzes starch and complex carbohydrates. So, the higher the amount of these nutrients in the body, the more is the requirement of amylase. Eventually, the level of amylase falls down from the normal recommended level, thus manifesting amylase deficiency symptoms[30,31]. Diabetes does not only cause impairment in the metabolism of sugars but is also associated with abnormal metabolism of fats and proteins. Therefore all three key enzymes — lipase, protease and amylase — are important in managing diabetes because they will help digest all three groups of nutrients: proteins, fats and sugars[16]. [/I] [B] [I]5. Conclusions[/I] [/B] [I]Although most of diabetic research has been focused on dyslipidemia as a major risk factor for cardiac, cerebral and renal complications, the present study clearly illustrates an impairment of pancreatic exocrine function in type 2 diabetes mellitus. The suggestion that an analysis of serum pancreatic enzymes could be an additional informative parameter for the assessment of chronic and progress of the illness as well as the response to therapy."[/I] [/QUOTE]
Verification
Post Reply
Home
Forums
Food and Nutrition
Low-carb Diet Forum
Digestive Enzymes: An Unexpected Diabetes Game Changer
Top
Bottom
Find support, ask questions and share your experiences. Ad free.
Join the community »
This site uses cookies. By continuing to use this site, you are agreeing to our use of cookies.
Accept
Learn More.…